Idvynso Approval Gives Merck A Competitor In Once-Daily Oral HIV Market

 
• By Joseph Haas
  
Merck sign atop Merck Research Laboratories campus in South San Francisco
Merck's islatravir earns first US approval as part of combo regimen for HIV • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Approvals & Launches

More from Scrip